Martinez‐Urbistondo, D., Huerta, A., Navarro‐González, D., Sánchez‐Iñigo, L., Fernandez‐Montero, A., Landecho, M. F., . . . Pastrana‐Delgado, J. C. (2023). Estimation of fatty liver disease clinical role on glucose metabolic remodelling phenotypes and T2DM onset. European Journal of Clinical Investigation, 53(10), 1. https://doi.org/10.1111/eci.14036
Chicago Style (17th ed.) CitationMartinez‐Urbistondo, Diego, Ana Huerta, David Navarro‐González, Laura Sánchez‐Iñigo, Alejandro Fernandez‐Montero, Manuel F. Landecho, J. Alfredo Martinez, and Juan C. Pastrana‐Delgado. "Estimation of Fatty Liver Disease Clinical Role on Glucose Metabolic Remodelling Phenotypes and T2DM Onset." European Journal of Clinical Investigation 53, no. 10 (2023): 1. https://doi.org/10.1111/eci.14036.
MLA (9th ed.) CitationMartinez‐Urbistondo, Diego, et al. "Estimation of Fatty Liver Disease Clinical Role on Glucose Metabolic Remodelling Phenotypes and T2DM Onset." European Journal of Clinical Investigation, vol. 53, no. 10, 2023, p. 1, https://doi.org/10.1111/eci.14036.
